BR9509076A - Molécula de dna isolada e purificada vetor de expressão proteína anticorpo monoespecífico composto composição farmacêutica vacina e processos para expressar preteina de papilomavírus humano tipo 6a para identificar compostos e para induzir respostas imunes contra infecção ou doença provocada por papilomavírus humano - Google Patents
Molécula de dna isolada e purificada vetor de expressão proteína anticorpo monoespecífico composto composição farmacêutica vacina e processos para expressar preteina de papilomavírus humano tipo 6a para identificar compostos e para induzir respostas imunes contra infecção ou doença provocada por papilomavírus humanoInfo
- Publication number
- BR9509076A BR9509076A BR9509076A BR9509076A BR9509076A BR 9509076 A BR9509076 A BR 9509076A BR 9509076 A BR9509076 A BR 9509076A BR 9509076 A BR9509076 A BR 9509076A BR 9509076 A BR9509076 A BR 9509076A
- Authority
- BR
- Brazil
- Prior art keywords
- human papillomavirus
- pretein
- disease
- isolated
- processes
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 108020004414 DNA Proteins 0.000 title 1
- 102000053602 DNA Human genes 0.000 title 1
- 241001502561 Human papillomavirus type 6a Species 0.000 title 1
- 208000009608 Papillomavirus Infections Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000013604 expression vector Substances 0.000 title 1
- 208000021145 human papilloma virus infection Diseases 0.000 title 1
- 230000028993 immune response Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31046894A | 1994-09-22 | 1994-09-22 | |
PCT/US1995/011859 WO1996009375A1 (fr) | 1994-09-22 | 1995-09-18 | Adn codant pour le papillomavirus humain du type 6a |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9509076A true BR9509076A (pt) | 1998-07-14 |
Family
ID=23202654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9509076A BR9509076A (pt) | 1994-09-22 | 1995-09-18 | Molécula de dna isolada e purificada vetor de expressão proteína anticorpo monoespecífico composto composição farmacêutica vacina e processos para expressar preteina de papilomavírus humano tipo 6a para identificar compostos e para induzir respostas imunes contra infecção ou doença provocada por papilomavírus humano |
Country Status (16)
Country | Link |
---|---|
US (1) | US6290965B1 (fr) |
EP (1) | EP0782615A4 (fr) |
JP (1) | JPH10506014A (fr) |
AU (1) | AU694269B2 (fr) |
BG (1) | BG101338A (fr) |
BR (1) | BR9509076A (fr) |
CA (1) | CA2200582C (fr) |
CZ (1) | CZ87597A3 (fr) |
FI (1) | FI121507B (fr) |
HU (1) | HUT77337A (fr) |
NO (1) | NO971347L (fr) |
NZ (1) | NZ293461A (fr) |
PL (1) | PL319294A1 (fr) |
RU (1) | RU2177999C2 (fr) |
SK (1) | SK35897A3 (fr) |
WO (1) | WO1996009375A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6962981B1 (en) * | 1996-03-25 | 2005-11-08 | Medarex, Inc. | Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
PT1105466E (pt) * | 1998-08-14 | 2006-07-31 | Merck & Co Inc | Processo para a purificacao de particulas tipo virus do papilomavirus humano |
CN1100835C (zh) * | 1998-10-30 | 2003-02-05 | 中国科学院感光化学研究所 | 加入纳米无机化合物粒子的钛溶胶-凝胶涂料及其制法和用途 |
GB0017990D0 (en) * | 2000-07-21 | 2000-09-13 | Glaxo Group Ltd | Papilloma virus sequences |
WO2004081178A2 (fr) * | 2003-03-06 | 2004-09-23 | Indiana University Research And Technology Corporation | Methodes et compositions pour produire des souches hpv infectieuses |
IL156670A0 (en) * | 2003-06-26 | 2004-01-04 | Zvi Zolotariov | Aloe suppositories |
US20090053261A1 (en) * | 2005-09-08 | 2009-02-26 | Lindbo John A | Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications |
US20080160040A1 (en) * | 2004-04-15 | 2008-07-03 | Ghim Shin-Je | Plant-produced compositions for treating papillomavirus infection and related methods |
CA2588581C (fr) | 2004-12-08 | 2011-05-31 | Gen-Probe Incorporated | Detection d'acides nucleiques de types multiples de papillomavirus humains |
US8084207B2 (en) * | 2005-03-03 | 2011-12-27 | Ibis Bioscience, Inc. | Compositions for use in identification of papillomavirus |
US20070031826A1 (en) * | 2005-08-05 | 2007-02-08 | My Gene | Diagnostic kit for determining the genotype of a human papilloma virus and method of using thereof |
KR100904844B1 (ko) * | 2006-08-28 | 2009-06-25 | 성균관대학교산학협력단 | 인유두종 바이러스(hpv)유전자를 포함하는자궁경부암의 치료 또는 예방용 dna 백신 |
PT2227546T (pt) * | 2007-12-21 | 2016-08-12 | Novartis Ag | Vector de expressão em mamíferos |
WO2011149897A1 (fr) | 2010-05-25 | 2011-12-01 | Qiagen Gaithersburg, Inc. | Analyse de capture hybride à résultats rapides et sondes associées tronquées de manière stratégique |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1835029A1 (fr) * | 1992-06-25 | 2007-09-19 | Georgetown University | Vaccins de papillomavirus |
JP3863559B2 (ja) * | 1994-05-16 | 2006-12-27 | メルク エンド カンパニー インコーポレーテッド | 乳頭腫ウィルスワクチン |
AR004464A1 (es) * | 1994-11-14 | 1998-12-16 | Merck Sharp & Dohme | Un metodo para producir una proteina de capside de papilomavirus |
IL117591A0 (en) * | 1995-03-30 | 1996-07-23 | Merck & Co Inc | Synthetic DNA encoding human papillomavirus type 11 L1 protein |
-
1995
- 1995-09-18 BR BR9509076A patent/BR9509076A/pt not_active Application Discontinuation
- 1995-09-18 CA CA002200582A patent/CA2200582C/fr not_active Expired - Lifetime
- 1995-09-18 HU HU9702290A patent/HUT77337A/hu unknown
- 1995-09-18 SK SK358-97A patent/SK35897A3/sk unknown
- 1995-09-18 PL PL95319294A patent/PL319294A1/xx unknown
- 1995-09-18 EP EP95933148A patent/EP0782615A4/fr not_active Ceased
- 1995-09-18 RU RU97106340/13A patent/RU2177999C2/ru active
- 1995-09-18 CZ CZ97875A patent/CZ87597A3/cs unknown
- 1995-09-18 WO PCT/US1995/011859 patent/WO1996009375A1/fr not_active Application Discontinuation
- 1995-09-18 NZ NZ293461A patent/NZ293461A/en unknown
- 1995-09-18 JP JP8511012A patent/JPH10506014A/ja active Pending
- 1995-09-18 AU AU35918/95A patent/AU694269B2/en not_active Expired
-
1997
- 1997-03-18 BG BG101338A patent/BG101338A/xx unknown
- 1997-03-21 FI FI971203A patent/FI121507B/fi not_active IP Right Cessation
- 1997-03-21 NO NO971347A patent/NO971347L/no not_active Application Discontinuation
-
2000
- 2000-03-08 US US09/521,526 patent/US6290965B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
RU2177999C2 (ru) | 2002-01-10 |
MX9702209A (es) | 1997-07-31 |
NO971347D0 (no) | 1997-03-21 |
AU3591895A (en) | 1996-04-09 |
BG101338A (en) | 1997-10-31 |
PL319294A1 (en) | 1997-08-04 |
AU694269B2 (en) | 1998-07-16 |
CA2200582C (fr) | 2007-03-27 |
FI971203A0 (fi) | 1997-03-21 |
FI971203A (fi) | 1997-03-21 |
EP0782615A1 (fr) | 1997-07-09 |
SK35897A3 (en) | 1998-02-04 |
NO971347L (no) | 1997-05-21 |
NZ293461A (en) | 1998-04-27 |
HUT77337A (hu) | 1998-03-30 |
US6290965B1 (en) | 2001-09-18 |
CZ87597A3 (cs) | 1998-01-14 |
FI121507B (fi) | 2010-12-15 |
WO1996009375A1 (fr) | 1996-03-28 |
JPH10506014A (ja) | 1998-06-16 |
CA2200582A1 (fr) | 1996-03-28 |
EP0782615A4 (fr) | 2001-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9509076A (pt) | Molécula de dna isolada e purificada vetor de expressão proteína anticorpo monoespecífico composto composição farmacêutica vacina e processos para expressar preteina de papilomavírus humano tipo 6a para identificar compostos e para induzir respostas imunes contra infecção ou doença provocada por papilomavírus humano | |
BR0214137A (pt) | Anticorpos para o cd40, composição farmacêutica compreendendo os mesmos, uso dos mesmos na fabricação de um medicamento, linhagem, de célula isolada, molécula de ácido nucléico isolada, vetor compreendendo a mesma, célula hospedeira e método de fabricação dos referidos anticorpos | |
PT712307E (pt) | Metodos para controlo da populacao de celulas b | |
ATE348113T1 (de) | Rekombinanter anti-cd4 antikörper zur menschlichen behandlung | |
BR9406007A (pt) | Construção de DNA, vacina de polinucleotídeos, vetor, processos para proteger contra infecção por vírus influenza humano, para usar um gene de vírus influenza, para induzir respostas imunes contra infecção ou doença provocada por cepas de vírus influenza, composição de construções de ácido nucleico e uso de um gene de vírus influenza humano | |
BR9508596A (pt) | Moduladores de peso de corpo correspondentes ácidos nucléicos e proteinas e usos diagnósticos e terapêuticos dos mesmos | |
DE68925226D1 (de) | Monoklonale Antikörper | |
FR2697022B1 (fr) | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. | |
BRPI9915208A (pt) | preparados farmacêutico e de comprimido para a aplicação oral compreendendo moxifloxacina e seu processo de preparação. | |
FI900808A0 (fi) | Humant mannos bindande protein. | |
BR9913446A (pt) | Produtos de aglicona e métodos de uso | |
NO20015828D0 (no) | Fremgangsmåter for fremstilling av 5'-nukleinsyre- proteinkonjugater | |
Hilleman | Immunologic, chemotherapeutic and interferon approaches to control of viral disease | |
ES2137310T3 (es) | Vacuna contra una infeccion por streptococcus suis. | |
BR9106159A (pt) | Polipeptideo sintetico,vacina,estojo para detectar hiv ou anticorpos contra hiv,molecula de dna,composicao farmaceutica,anticorpo ou fragmento de ligacao de antigeno do mesmo,processos de terapia ou profilaxia de infeccao hiv,de detectar hiv,de diagnosticar infeccao hiv e para a manufatura de um polipeptideo sintetico,de uma composicao farmaceutica e de um anticorpo ou fragmento de ligacao do mesmo | |
DE69737323D1 (de) | Adhesin aus heliobacter pylori, welches an blutgruppenantigene bindet | |
PT817851E (pt) | Dna codificador do virus do papiloma humano tipo 18 | |
FR2792831B1 (fr) | Composition a destination cosmetique et/ou dietetique comprenant un melange de lycopene et d'extrait de feuille d'olivier | |
RU97106340A (ru) | Днк, кодирующая папиломавирус типа 6а человека | |
BR0109164A (pt) | Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos | |
EA200100700A1 (ru) | Гены и белки и их применение | |
BR9609149A (pt) | Modificação de drogas de polopeptídeo para aumentar o fluxo por eletrotransporte | |
BR9916549A (pt) | Composição farmacêutica, vacina, proteìna, e, método para a prevenção ou tratamento de leishmaniose em um humano ou animal | |
SE9002212D0 (sv) | Igg binding protein | |
CS55990A3 (en) | Phenylhydrazones, process of their preparation and cosmetic preparations and pharmaceuticals made therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal |